Barrow, Hanley, Mewhinney & Strauss’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.68K Buy
47
+7
+18% +$255 ﹤0.01% 341
2025
Q4
$1.3K Buy
+40
New +$1.25K ﹤0.01% 322

Other funds holding CRI

Barrow, Hanley, Mewhinney & Strauss's CRI Position: Q1 2026 in Review

Barrow, Hanley, Mewhinney & Strauss increased its Carter's (CRI) stake by 18% in Q1 2026, buying an estimated $255 and bringing the position to 47 shares worth $1.68K. The position accounts for ﹤0.01% of the portfolio, ranked #341.

Barrow, Hanley, Mewhinney & Strauss first reported a position in CRI in Q4 2025 and has held it in 2 quarters since. 275 funds tracked by Wall St. Rank hold CRI as of Q1 2026.

  • Barrow, Hanley, Mewhinney & Strauss held 47 shares of Carter's worth $1.68K as of Q1 2026.
  • Barrow, Hanley, Mewhinney & Strauss bought 7 Carter's shares in Q1 2026, an estimated $255.
  • Carter's made up ﹤0.01% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q1 2026, its #341 holding.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Carter's in Q4 2025 and has held it in 2 quarters since.
  • 275 funds tracked by Wall St. Rank held Carter's as of Q1 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2026, filed 13 May 2026.